Drug dosing in obese surgery patients: new data on sugammadex
NCT ID NCT05328778
First seen May 01, 2026 · Last updated May 01, 2026
Summary
This study looked at how the drug sugammadex reverses vecuronium, a muscle relaxant used during laparoscopic (keyhole) surgery, in 48 obese patients. Researchers measured drug levels in the blood and how quickly muscle function returned. The goal was to better understand dosing for this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangzhou Military Region General Hospital, Department of Anesthesiology
Guangzhou, Guangdong, 510010, China
Conditions
Explore the condition pages connected to this study.